A plethysmograph is an instrument for measuring differences in volume within an organ or whole body. Pulmonary plethysmographs are used to measure the functional residual capacity (FRC) of the lungs, the volume in the lungs when the muscles of respiration are relaxed, and total lung capacity.
MARKET DYNAMICS
The rising prevalence of lung disorders owing to the consumption of tobacco & alcohol and sedentary lifestyles are anticipated to drive the plethysmograph market. However, the availability of alternative methods for plethysmography such as gas dilution tests and spirometry, which are also less expensive that is restraining the market growth. Moreover, its low cost and the fact that it is a less invasive procedure are expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Plethysmograph Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in plethysmograph market with detailed market segmentation by product type, industry and geography. The plethysmograph market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in plethysmograph market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The plethysmograph market is segmented on the basis of product type, and industry. Based on product type the market is segmented as body plethysmograph and limbs plethysmograph. On the basis of industry the market is categorized as adult and baby.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in plethysmograph market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The plethysmograph market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting plethysmograph market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the plethysmograph market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in plethysmograph market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The plethysmograph market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting plethysmograph market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the plethysmograph market in these regions.
MARKET PLAYERS
The report covers key developments in the in plethysmograph market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in plethysmograph market are anticipated to have lucrative growth opportunities in the future with the rising demand for in plethysmograph market in the global market. Below mentioned is the list of few companies engaged in the plethysmograph market.
The report also includes the profiles of key in plethysmograph market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Becton, Dickinson and Company (Carefusion)
- COSMED srl
- emka TECHNOLOGIES
- Ganshorn Medizin Electronic GmbH
- Geratherm Medical AG
- Medical Electronic Construction
- MGC Diagnostics Corporation
- PulmOne Advanced Medical Devices, Ltd.
- SCHILLER Healthcare India Pvt. Ltd.
- Vyaire Medical Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-Venom Market - By Type
1.3.2 Anti-Venom Market - By Reptile
1.3.3 Anti-Venom Market - By Mode of Action
1.3.4 Anti-Venom Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI-VENOM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI-VENOM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANTI-VENOM MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-VENOM - GLOBAL MARKET OVERVIEW
6.2. ANTI-VENOM - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI-VENOM MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOVALENT ANTIVENOM
7.3.1. Overview
7.3.2. Monovalent Antivenom Market Forecast and Analysis
7.4. POLYVALENT ANTIVENOM
7.4.1. Overview
7.4.2. Polyvalent Antivenom Market Forecast and Analysis
8. ANTI-VENOM MARKET - REVENUE AND FORECASTS TO 2028 - REPTILE
8.1. OVERVIEW
8.2. REPTILE MARKET FORECASTS AND ANALYSIS
8.3. SNAKE
8.3.1. Overview
8.3.2. Snake Market Forecast and Analysis
8.4. SCORPION
8.4.1. Overview
8.4.2. Scorpion Market Forecast and Analysis
8.5. SPIDER
8.5.1. Overview
8.5.2. Spider Market Forecast and Analysis
8.6. OTHERS (IF ANY)
8.6.1. Overview
8.6.2. Others (If Any) Market Forecast and Analysis
9. ANTI-VENOM MARKET - REVENUE AND FORECASTS TO 2028 - MODE OF ACTION
9.1. OVERVIEW
9.2. MODE OF ACTION MARKET FORECASTS AND ANALYSIS
9.3. CYTOTOXIC
9.3.1. Overview
9.3.2. Cytotoxic Market Forecast and Analysis
9.4. NEUROTOXIC
9.4.1. Overview
9.4.2. Neurotoxic Market Forecast and Analysis
9.5. HAEMOTOXIC
9.5.1. Overview
9.5.2. Haemotoxic Market Forecast and Analysis
9.6. CARDIOTOXIC
9.6.1. Overview
9.6.2. Cardiotoxic Market Forecast and Analysis
9.7. MYOTOXIC
9.7.1. Overview
9.7.2. Myotoxic Market Forecast and Analysis
9.8. OTHERS (IF ANY)
9.8.1. Overview
9.8.2. Others (If Any) Market Forecast and Analysis
10. ANTI-VENOM MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anti-Venom Market Overview
10.1.2 North America Anti-Venom Market Forecasts and Analysis
10.1.3 North America Anti-Venom Market Forecasts and Analysis - By Type
10.1.4 North America Anti-Venom Market Forecasts and Analysis - By Reptile
10.1.5 North America Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.1.6 North America Anti-Venom Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anti-Venom Market
10.1.6.1.1 United States Anti-Venom Market by Type
10.1.6.1.2 United States Anti-Venom Market by Reptile
10.1.6.1.3 United States Anti-Venom Market by Mode of Action
10.1.6.2 Canada Anti-Venom Market
10.1.6.2.1 Canada Anti-Venom Market by Type
10.1.6.2.2 Canada Anti-Venom Market by Reptile
10.1.6.2.3 Canada Anti-Venom Market by Mode of Action
10.1.6.3 Mexico Anti-Venom Market
10.1.6.3.1 Mexico Anti-Venom Market by Type
10.1.6.3.2 Mexico Anti-Venom Market by Reptile
10.1.6.3.3 Mexico Anti-Venom Market by Mode of Action
10.2. EUROPE
10.2.1 Europe Anti-Venom Market Overview
10.2.2 Europe Anti-Venom Market Forecasts and Analysis
10.2.3 Europe Anti-Venom Market Forecasts and Analysis - By Type
10.2.4 Europe Anti-Venom Market Forecasts and Analysis - By Reptile
10.2.5 Europe Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.2.6 Europe Anti-Venom Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anti-Venom Market
10.2.6.1.1 Germany Anti-Venom Market by Type
10.2.6.1.2 Germany Anti-Venom Market by Reptile
10.2.6.1.3 Germany Anti-Venom Market by Mode of Action
10.2.6.2 France Anti-Venom Market
10.2.6.2.1 France Anti-Venom Market by Type
10.2.6.2.2 France Anti-Venom Market by Reptile
10.2.6.2.3 France Anti-Venom Market by Mode of Action
10.2.6.3 Italy Anti-Venom Market
10.2.6.3.1 Italy Anti-Venom Market by Type
10.2.6.3.2 Italy Anti-Venom Market by Reptile
10.2.6.3.3 Italy Anti-Venom Market by Mode of Action
10.2.6.4 Spain Anti-Venom Market
10.2.6.4.1 Spain Anti-Venom Market by Type
10.2.6.4.2 Spain Anti-Venom Market by Reptile
10.2.6.4.3 Spain Anti-Venom Market by Mode of Action
10.2.6.5 United Kingdom Anti-Venom Market
10.2.6.5.1 United Kingdom Anti-Venom Market by Type
10.2.6.5.2 United Kingdom Anti-Venom Market by Reptile
10.2.6.5.3 United Kingdom Anti-Venom Market by Mode of Action
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anti-Venom Market Overview
10.3.2 Asia-Pacific Anti-Venom Market Forecasts and Analysis
10.3.3 Asia-Pacific Anti-Venom Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Anti-Venom Market Forecasts and Analysis - By Reptile
10.3.5 Asia-Pacific Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.3.6 Asia-Pacific Anti-Venom Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anti-Venom Market
10.3.6.1.1 Australia Anti-Venom Market by Type
10.3.6.1.2 Australia Anti-Venom Market by Reptile
10.3.6.1.3 Australia Anti-Venom Market by Mode of Action
10.3.6.2 China Anti-Venom Market
10.3.6.2.1 China Anti-Venom Market by Type
10.3.6.2.2 China Anti-Venom Market by Reptile
10.3.6.2.3 China Anti-Venom Market by Mode of Action
10.3.6.3 India Anti-Venom Market
10.3.6.3.1 India Anti-Venom Market by Type
10.3.6.3.2 India Anti-Venom Market by Reptile
10.3.6.3.3 India Anti-Venom Market by Mode of Action
10.3.6.4 Japan Anti-Venom Market
10.3.6.4.1 Japan Anti-Venom Market by Type
10.3.6.4.2 Japan Anti-Venom Market by Reptile
10.3.6.4.3 Japan Anti-Venom Market by Mode of Action
10.3.6.5 South Korea Anti-Venom Market
10.3.6.5.1 South Korea Anti-Venom Market by Type
10.3.6.5.2 South Korea Anti-Venom Market by Reptile
10.3.6.5.3 South Korea Anti-Venom Market by Mode of Action
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anti-Venom Market Overview
10.4.2 Middle East and Africa Anti-Venom Market Forecasts and Analysis
10.4.3 Middle East and Africa Anti-Venom Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Anti-Venom Market Forecasts and Analysis - By Reptile
10.4.5 Middle East and Africa Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.4.6 Middle East and Africa Anti-Venom Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anti-Venom Market
10.4.6.1.1 South Africa Anti-Venom Market by Type
10.4.6.1.2 South Africa Anti-Venom Market by Reptile
10.4.6.1.3 South Africa Anti-Venom Market by Mode of Action
10.4.6.2 Saudi Arabia Anti-Venom Market
10.4.6.2.1 Saudi Arabia Anti-Venom Market by Type
10.4.6.2.2 Saudi Arabia Anti-Venom Market by Reptile
10.4.6.2.3 Saudi Arabia Anti-Venom Market by Mode of Action
10.4.6.3 U.A.E Anti-Venom Market
10.4.6.3.1 U.A.E Anti-Venom Market by Type
10.4.6.3.2 U.A.E Anti-Venom Market by Reptile
10.4.6.3.3 U.A.E Anti-Venom Market by Mode of Action
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anti-Venom Market Overview
10.5.2 South and Central America Anti-Venom Market Forecasts and Analysis
10.5.3 South and Central America Anti-Venom Market Forecasts and Analysis - By Type
10.5.4 South and Central America Anti-Venom Market Forecasts and Analysis - By Reptile
10.5.5 South and Central America Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.5.6 South and Central America Anti-Venom Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anti-Venom Market
10.5.6.1.1 Brazil Anti-Venom Market by Type
10.5.6.1.2 Brazil Anti-Venom Market by Reptile
10.5.6.1.3 Brazil Anti-Venom Market by Mode of Action
10.5.6.2 Argentina Anti-Venom Market
10.5.6.2.1 Argentina Anti-Venom Market by Type
10.5.6.2.2 Argentina Anti-Venom Market by Reptile
10.5.6.2.3 Argentina Anti-Venom Market by Mode of Action
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTI-VENOM MARKET, KEY COMPANY PROFILES
12.1. ALOMONE LABS, LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BTG INTERNATIONAL LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CSL LIMITED
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. FLYNN PHARMA (MICROPHARM)
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HAFFKINE BIO-PHARMACEUTICAL CORPORATION LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LABORATORIOS SILANES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK AND CO.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SIGMA-ALDRICH CO.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Becton, Dickinson and Company (Carefusion)
2. COSMED srl
3. emka TECHNOLOGIES
4. Ganshorn Medizin Electronic GmbH
5. Geratherm Medical AG
6. Medical Electronic Construction
7. MGC Diagnostics Corporation
8. PulmOne Advanced Medical Devices, Ltd.
9. SCHILLER Healthcare India Pvt. Ltd.
10. Vyaire Medical Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Plethysmograph Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)